Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Quarterly Report · 10-Q

COOPER COMPANIES, INC.

Quarterly Report

Filed Mar 3, 2023Accepted Mar 3, 2023, 4:16 PM ESTCIK 711404Accession 0000711404-23-000013
Share

Company context

CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.

Current securities

Recent company filings

  1. 4 filingSep 17, 2026
  2. 4 filingSep 15, 2026
  3. 10-Q filingSep 9, 2026
  4. Results of Operations and Financial Condition · Other EventsSep 9, 2026
  5. 4 filingJul 6, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗